Wall Street’s major indices ended the trading week on a strong note, clocking in robust gains as investors cheered better-than-expected non-farm payrolls last month while digesting more corporate earnings results.

The tech-heavy Nasdaq led the rally among all major indices, finishing up 1.51 percent. The S&P 500 clocked in a 1.47-percent gain, while the Dow Jones grew by 1.39 percent.

Despite the broader market optimism, 10 companies managed to register declines amid dismal earnings performance in the first quarter of the year. In this article, let us explore Friday’s 10 worst performers and the reasons behind their decline.

To come up with the list, we considered only the stocks with a $2-billion market capitalization and $5-million trading volume.

10. Golar LNG Limited (NASDAQ:GLNG)

Golar LNG snapped an eight-day winning streak on Friday, dropping 6.84 percent to close at $39.64 each as investors resorted to profit-taking to take advantage of gains from the previous days’ rally.

In recent news, Golar LNG Limited (NASDAQ:GLNG) said that it expects to rake in some $13.7 billion from two long-term charter agreements, which include the 20-year deployment of its FLNG Hilli Episeyo vessel to serve Southern Energy SA off the coast of Argentina.

In parallel, Golar LNG Limited (NASDAQ:GLNG) also signed another 20-year binding contract for its MKII FLNG vessel, which is currently under transformation at a shipyard in Yantai, China.

According to the company, a notable provision allows it to earn approximately $100 million for each dollar increase above $8 per mmbtu, once both vessels become fully operational.

Additionally, Southern Energy has the option to shorten its charter to 12 years for FLNG Hilli and 15 years for MKII FLNG, subject to a three-year notice and associated fees.

9. Alignment Healthcare, Inc. (NASDAQ:ALHC)

Alignment Healthcare dropped its share prices by 7.39 percent on Friday to finish at $15.53 apiece as investors immediately booked profits after a surge during the intra-day session, supported by its impressive earnings performance in the first quarter of the year.

In a statement, Alignment Healthcare, Inc. (NASDAQ:ALHC) said that it narrowed its net loss by 80 percent to $9.35 million from $46.5 million in the same period last year.

Revenues increased by 47 percent to $927 million from $629 million year-on-year.

Looking ahead, the company said that it is gunning for revenues between $950 million and $965 million in the second quarter of the year, to between $3.77 billion and $3.8 billion in the full-year period.

Adjusted EBITDA is also expected to settle at $10 to $18 million in the second quarter, and to $38 to $60 million in full-year 2025.

“By staying focused on quality, clinical outcomes, and member experience, we exceeded expectations across all key measures. With a strong start to the year and momentum building, we’re confident in our ability to scale with purpose and deliver on our mission of Medicare Advantage done right,” said Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John Kao.

8. Roku, Inc. (NASDAQ:ROKU)

Roku Inc. dropped its share prices by 8.5 percent on Friday to close at $61.55 apiece as investors shunned the company’s strong earnings performance for the first quarter of the year.

In its latest earnings release, Roku, Inc. (NASDAQ:ROKU) said that net loss narrowed by 46 percent to $27.4 million from $50.8 million in the same period a year earlier. Net revenues increased by 15.77 percent to $1.02 billion from $881 million year-on-year.

Looking ahead, the company expects net loss to further shrink to $25 million in the second quarter and end at $30 million in full-year 2025.

Net revenues are expected to settle at $1.07 billion in the current quarter and at $4.55 billion for the full-year period.

“We remain vigilant and adaptable as market conditions evolve. While uncertainty remains, we are confident in our strategy and continue to see a path to achieving positive operating income in 2026,” said Roku, Inc. (NASDAQ:ROKU).

7. Atlassian Corporation (NASDAQ:TEAM)

Atlassian Corp. dropped its share prices by 8.99 percent on Friday to finish at $208.48 apiece as investors sold off positions following its disappointing earnings performance during the past quarter of the year.

In a statement, Atlassian Corporation (NASDAQ:TEAM) said that net loss in the first quarter of the year expanded by 288 percent to $123.8 million from the $31.9 million registered in the same period last year.

Revenues, on the other hand, rose by 21 percent to $1.187 billion from $977.8 million in the same comparable period.

Atlassian Corporation (NASDAQ:TEAM) referred to its performance as a “solid start,” saying that it will continue to focus its investment and execution against its key strategic priorities of serving the enterprise, delivering AI innovation, among others.

For the second quarter of the year, Atlassian Corporation (NASDAQ:TEAM) said it expects total revenues to settle anywhere between $1.23 billion and $1.24 billion, with cloud revenue expected to grow 25.5 percent year-on-year.

For the full year 2025, the company targets to grow between 16.5 percent and 17 percent.

6. Huntsman Corporation (NYSE:HUN)

Huntsman Corp. dropped its share prices by 9.35 percent on Friday to finish at $12.12 apiece following a mixed earnings performance in the first quarter of the year, coupled with a soft outlook guidance for the rest of the year.

In a statement, Huntsman Corporation (NYSE:HUN) said that its net loss attributable to the company narrowed by 86 percent to $5 million from $37 million in the same period last year.

Revenues, on the other hand, declined by 4 percent to $1.41 billion from $1.47 billion year-on-year.

“Since our last earnings call, short-term business conditions continue to change markedly. Low visibility and customer uncertainty regarding demand trends over the coming months are pressuring order patterns in many of our key markets, including construction, transportation, and other industrial-related markets. The cautious customer order patterns are muting the seasonal volume improvement our markets typically experience during the second quarter,” said Huntsman Corporation (NYSE:HUN) Chairman, President, and CEO Peter Huntsman.

“While we are hopeful that demand conditions improve, we are not waiting for that to happen and remain aggressive on costs, which include announced workforce reductions as well as asset optimization in both Europe and North America,” he added.

5. Liberty Global Ltd. (NASDAQ:LBTYA)

Liberty Global declined for a third day on Friday, losing 11.4 percent to finish at $9.64 apiece as investors soured on its dismal earnings performance in the past quarter.

In a statement, Liberty Global Ltd. (NASDAQ:LBTYA) said it swung to a loss from continuing operations of $1.3 billion from a $634.5 million income in the same period last year.

Revenues, however, rose by 7.3 percent to $1.17 billion from $1.09 billion in the same comparable period.

“Across the group, our clear focus on unlocking shareholder value remains, as we resumed buybacks during the quarter towards our ‘up to 10% of shares’ target for 2025,” Liberty Global Ltd. (NASDAQ:LBTYA) CEO Mike Fries said.

“Our guidance at the Liberty Global corporate level remains unchanged, as does the guidance for all of our Liberty Telecom operations with the exception of VodafoneZiggo, where we have revised guidance to align with management’s new long-term growth strategy,” he added.

4. Viavi Solutions Inc. (NASDAQ:VIAV)

Viavi Solutions saw its share prices fall by 12.30 percent on Friday to end at $9.34 apiece as investors soured on its lower-than-expected guidance for the fourth quarter of fiscal year 2025.

According to the company, it expects earnings per share in the fourth quarter to settle between $0.10 and $0.13, way below the consensus estimate of $0.14.

It also targets revenues to end between $278 million and $290 million, as against the $293.6 million as expected by analysts.

During the third quarter, Viavi Solutions Inc. (NASDAQ:VIAV) swung to a net income of $19.5 million from a net loss of $24.6 million. Net revenues increased by 15.8 percent to $284.8 million from $246 million year-on-year.

For the nine-month period, the company swung to a net income of $26.8 million from a net loss of $4.1 million year-on-year. Net revenues also rose by 6 percent to $793.8 million from $748.4 million in the same comparable period.

3. Cytokinetics, Inc. (NASDAQ:CYTK)

Cytokinetics fell by 12.98 percent on Friday to finish at $37.35 apiece as investor sentiment was weighed down by the Food and Drug Administration’s (FDA) decision to delay its approval of the company’s heart treatment.

According to the FDA, it asked Cytokinetics, Inc. (NASDAQ:CYTK) for the risk evaluation and mitigation strategy of aficamten, which pushed back the result of its review to December 26 from the original target date of September. The company said it had already complied with the request.

Aficamten is currently under review as a treatment for obstructive hypertrophic cardiomyopathy, a heart disorder in which cardiac muscle becomes abnormally thick, making it harder for the heart to pump blood.

“We believe the commercial prospects of aficamten are highly dependent on whether FDA approves aficamten with a label and/or post-marketing conditions that are less challenging to prescribers and patients than the REMS applicable to Camzyos, Cytokinetics, Inc. (NASDAQ:CYTK) said in its report.

For his part, Cytokinetics President and CEO Robert Blum said that he “remains confident in the distinct benefit-risk and pharmaceutic profile of aficamten and continues to expect a differentiated label and risk mitigation profile upon its potential approval by the FDA.”

2. Hecla Mining Company (NYSE:HL)

Hecla Mining declined by 17 percent on Friday to end at $4.54 apiece as investor sentiment was dampened by an investment firm’s rating downgrade on its stock.

In its market note, BMO Capital lowered its rating for Hecla Mining Company (NYSE:HL) to Market Perform from Outperform previously, while reducing its price target to $5.50 from $7.5.

According to BMO Capital, the adjustment was based on the company’s persistent challenges in ramping up operations at Keno Hill, coupled with uncertainties over its Casa Berardi site.

Meanwhile, Hecla Mining Company (NYSE:HL) officially entered the oversold territory, having hit an RSI index of 28.8.

In the first quarter of the year, Hecla Mining Company (NYSE:HL) swung to a net income of $28.7 million from a $5.89 million net loss in the same period a year earlier.

Sales amounted to $261 million, higher by 38 percent than the $189 million registered in the same period last year.

1. Block, Inc. (NYSE:XYZ)

Block Inc. nosedived by 20.43 percent on Friday to finish at $46.53 apiece as investor sentiment was dampened by the company’s reduced profit forecast that pushed eight brokerages to lower their price targets on its stock.

In its latest earnings release, Block, Inc. (NYSE:XYZ) said it now projects its profits for full-year 2025 to grow between 12 and 15 percent and second quarter gross profit at $2.45 billion, well below the $2.54 billion as expected by analysts.

The trimmed forecast was due to concerns about consumer spending amid global market uncertainties brought about by President Donald Trump’s tariff policies.

“We are operating in a more dynamic macro environment, so we have reflected a more cautious stance on the macro outlook into our guidance for the rest of the year,” the company said.

In the first quarter of the year, Block, Inc. (NYSE:XYZ) dropped its net income by 60 percent as it registered a $93.4 million remeasurement loss on its Bitcoin holdings.

While we acknowledge the potential of XYZ as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than XYZ but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.